Tags
Asthma, Clinical and Translational Science Institute, Perelmen School of Medicine, Rutgers Biomedical and Health Sciences, Rutgers Research, Rutgers today, University of Pennsylvania
Scientists Reynold A. Panettieri, inaugural director of the Clinical and Translational Science Institute at Rutgers Biomedical and Health Sciences, and Edward E. Morrissey, director of the Penn Center for Pulmonary Biology, Perelmen School of Medicine at University of Pennsylvania, have identified a biological pathway that could explain why current asthma therapies often prove ineffective. The discovery has the potential to lead to new treatments for many of the 25 million people in the U.S., including seven million children, who suffer from the chronic condition.
Read the full story here.